Skip to main content
. Author manuscript; available in PMC: 2022 Nov 3.
Published in final edited form as: Am J Obstet Gynecol MFM. 2020 Dec 28;3(2):100304. doi: 10.1016/j.ajogmf.2020.100304

Table 3.

Risk differences of persistent opioid use and misuse among mothers with or without exposure to opioids after vaginal delivery in Medicaid Analytic eXtract 2009–2013

Analysis Risk Difference, % (95% CI)
Primary outcome
≥10 opioid prescription fills/ >120 days’ supply
 Unadjusted 3.26 (3.15 – 3.37)
 1:1 propensity score matching 2.21 (2.08 – 2.33)
 Instrumental variable analysis 1.31 (1.06 – 1.56)
Secondary outcome
≥180 days’ supply opioids
 Unadjusted 1.48 (1.41 – 1.55)
 1:1 propensity score matching 1.01 (0.93 – 1.10)
 Instrumental variable analysis 0.57 (0.39 – 0.74)
Opioid use disorder
 Unadjusted 1.57 (1.48 – 1.67)
 1:1 propensity score matching 0.81 (0.69 – 0.92)
 Instrumental variable analysis 1.26 (1.02 – 1.50)
Overdose
 Unadjusted 0.02 (0.01 – 0.04)
 1:1 propensity score matching 0.02 (0.01 – 0.03)
 Instrumental variable analysis 0.04 (0.01 – 0.07)